Susquehanna Fundamental Investments’s Collegium Pharmaceutical COLL Stock Holding History

Susquehanna Fundamental Investments’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,112	Closed	-$391K	–	782
2025 Q1	$391K	Buy	+13,112	New	+$401K	0.01%	897
2023 Q2	–	Sell	-32,516	Closed	-$780K	–	688
2023 Q1	$780K	Hold	32,516	–	–	0.02%	575
2022 Q4	$754K	Buy	32,516 +4,668	+17%	+$94.1K	0.01%	742
2022 Q3	$446K	Buy	+27,848	New	+$491K	0.01%	1055
2022 Q1	$412K	Buy	+20,234	New	+$382K	0.01%	1147
2021 Q4	–	Sell	-12,200	Closed	-$241K	–	1493
2021 Q3	$241K	Buy	+12,200	New	+$264K	﹤0.01%	1477

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna Fundamental Investments's COLL Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 13,112 shares — an estimated $391K sold.

Susquehanna Fundamental Investments first reported a position in COLL in Q3 2021 and held it in 6 quarters. The position peaked at $780K in Q1 2023. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 13,112 Collegium Pharmaceutical shares in Q2 2025, an estimated $391K.
Susquehanna Fundamental Investments first reported a position in Collegium Pharmaceutical in Q3 2021 and held it in 6 quarters.
Susquehanna Fundamental Investments's Collegium Pharmaceutical position peaked at $780K in Q1 2023.
223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.